RET Inhibitor SPP86 Is a Potential Candidate for the Clinical Treatment of Cutaneous Melanoma [Letter]

Yingjian Tan, Rui Li Department of Dermatology, Fuzhou First General Hospital, Fuzhou, People’s Republic of ChinaCorrespondence: Rui Li, Email 15773250213@163.com

Saved in:
Bibliographic Details
Main Authors: Tan Y, Li R
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/ret-inhibitor-spp86-is-a-potential-candidate-for-the-clinical-treatmen-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!